CAMP4 Therapeutics Corporation (CAMP) vs EyePoint Pharmaceuticals, Inc. (EYPT)
A side-by-side comparison of CAMP4 Therapeutics Corporation and EyePoint Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CAMP
CAMP4 Therapeutics Corporation
$4.01HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
EYPT
EyePoint Pharmaceuticals, Inc.
$3.15HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CAMP vs EYPT
growth of $100 · dividends reinvested · last 2yCAMP -62.6% (-38.8%/yr)EYPT -63.8% (-39.9%/yr)CAMP compounded faster over this window
CAMP EYPT
CAMP vs EYPT: by the numbers
- •EYPT is the larger company ($264M vs $252M market cap).
- •Both run net losses; CAMP's is the smaller (-2543.74% vs -10994.73% net margin).
- •Both shrank revenue over the past five years; EYPT's decline was smaller (-41.05% vs -57.68% CAGR).
Metrics side by side
Valuation
| Metric | CAMP | EYPT |
|---|---|---|
| P/S ratio | 59.69 | 94.69 |
| P/B ratio | N/A | 1.59 |
Profitability
| Metric | CAMP | EYPT |
|---|---|---|
| Gross margin | 53.14% | 93.41% |
| Operating margin | -1488.31% | -775.98% |
| Net margin | -2543.74% | -10994.73% |
| ROE | N/A | -184.27% |
| ROIC | -69.76% | -170.19% |
Growth (annualized)
| Metric | CAMP | EYPT |
|---|---|---|
| Revenue CAGR (5Y) | -57.68% | -41.05% |
| Total return CAGR (5Y) | N/A | -21.68% |
Frequently asked
- Which has grown faster, CAMP or EYPT?
- Neither grew: over the past five years both shrank revenue, with EYPT's decline the smaller — CAMP at a -57.68% CAGR versus EYPT at -41.05%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.